IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG

Immunotherapy
Melvin BergerOrell Mielke

Abstract

Subcutaneous IgG (SCIG) administration may be preferred over the intravenous route (IVIG) in chronic inflammatory demyelinating polyneuropathy (CIDP) because it minimizes 'end of cycle' treatment-related fluctuations, reduces systemic adverse effects, improves convenience/quality of life and potentially lowers overall costs. Early reports of the use of highly concentrated SCIG preparations suggested they were effective and well-tolerated in chronic inflammatory demyelinating polyneuropathy. This was confirmed in the Polyneuropathy and Treatment with Hizentra® study of 172 subjects randomized to receive maintenance therapy with placebo or one of two doses of IgPro20 (20% IgG stabilized with L-Proline) for 6 months. Risk of relapse was reduced by SCIG in a dose-related manner as compared with placebo. A total of 88% of polyneuropathy and treatment with hizentra subjects felt the subcutaneous method was 'easy to learn'. Local adverse events were mostly mild or moderate, and systemic adverse events were infrequent. Some patients may prefer maintenance therapy with SCIG over IVIG.

References

Mar 14, 1992·Lancet·W H Reinhart, P E Berchtold
Apr 1, 1982·Journal of the Neurological Sciences·K J SmithS M Hall
Jan 23, 1999·The New England Journal of Medicine·Z Yu, V A Lennon
Jun 23, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Melvin Berger
Nov 23, 2006·Journal of the Peripheral Nervous System : JPNS·Yusuf A RajaballyPatrick Wilson
Oct 23, 2008·Immunology and Allergy Clinics of North America·Francisco A Bonilla
Feb 25, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T HarboJ Jakobsen
Nov 26, 2009·Biologicals : Journal of the International Association of Biological Standardization·Reinhard BolliPeter Lerch
May 12, 2010·Archives of Neurology·Norman LatovUNKNOWN IGIV-C CIDP Efficacy (ICE) Study Group
Jul 29, 2010·Muscle & Nerve·Vera BrilUNKNOWN ICE Study Group
Jan 25, 2011·Biologicals : Journal of the International Association of Biological Standardization·Werner MaederReinhard Bolli
Mar 1, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Melvin BergerOthmar Zenker
Apr 21, 2011·Journal of the Peripheral Nervous System : JPNS·John D Pollard, Patricia J Armati
May 11, 2011·Clinical Pharmacokinetics·Richard L WassermanJoseph A Church
Jan 9, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H MarkvardsenUNKNOWN Danish CIDP and MMN Study Group
Mar 30, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Krista KuitwaardBart C Jacobs
Jul 3, 2013·Postgraduate Medicine·Randy BroylesMelvin Berger
Jul 10, 2013·Transfusion Medicine Reviews·E Richard Stiehm
Nov 26, 2013·Journal of the Neurological Sciences·M A HellmannI Steiner
Jan 29, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Carlo LazzaroDario Cocito
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Melvin Berger
Mar 13, 2014·Journal of the Peripheral Nervous System : JPNS·Eduardo Nobile-Orazio
Jul 22, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L H MarkvardsenUNKNOWN Danish CIDP and MMN Study Group
Nov 25, 2014·Muscle & Nerve·Melvin Berger, Jeffrey A Allen
Jun 23, 2015·Basic & Clinical Pharmacology & Toxicology·Lars H MarkvardsenJohannes Jakobsen
Jun 26, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Dario CocitoLeonardo Lopiano
Aug 8, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Mary LucasHelen Chapel
Jun 3, 2016·Journal of the Peripheral Nervous System : JPNS·Dario CocitoAristide Merola
Dec 9, 2016·Neurology·H Stephan GoedeeLeonard H van den Berg

❮ Previous
Next ❯

Methods Mentioned

BETA
ICE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Lars H MarkvardsenDanish CIDP and MMN Study Group
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Lars H MarkvardsenDanish CIDP and MMN Study Group
Electroencephalography and Clinical Neurophysiology. Supplement
F G Van der Meché, P A van Doorn
© 2022 Meta ULC. All rights reserved